Minnesota Connect


Archive for the ‘Health’


Another slam to retiree health benefits

In case you missed it, the Wall Street Journal yesterday reported:

GM’s announcement Tuesday that it would cease medical coverage for its salaried retirees age 65 and above signals that a new era of ever-shrinking benefits has arrived. Beginning in January, even former employees who are already in retirement will lose their benefits, which most of the company’s retirees use to supplement gaps in their traditional Medicare coverage. The auto maker will boost monthly pension payouts to help offset the cuts. The company’s unionized workers aren’t affected by the cut to retiree health benefits.

GM isn’t the first company to do this, but its heft and influence could help usher in further cutbacks at other companies. …

At this point, employees and retirees “have to feel lucky if they still have retiree [health-care] benefits, and have to start planning for when they won’t,” says Rick McGill, head of retiree medical consulting for employee-benefits firm Hewitt Associates. He says such benefits are “a dying breed.”

U.S. health system on the wrong track

In an announcement that got surprisingly little news attention, the Commonwealth Fund released its National Scorecard on U.S. Health System Performance, 2008. Excerpts: 693970.jpg

“The U.S. health system is on the wrong track. Overall, performance has not improved since the first National Scorecard was issued in 2006. Of greatest concern, access to health care has significantly declined. As of 2007, more than 75 million adults—42 percent of all adults ages 19 to 64—were either uninsured during the year or underinsured, up from 35 percent in 2003. At the same time, the U.S. failed to keep pace with gains in health outcomes achieved by the leading countries. The U.S. now ranks last out of 19 countries on a measure of mortality amenable to medical care, falling from 15th as other countries raised the bar on performance. Up to 101,000 fewer people would die prematurely if the U.S. could achieve leading, benchmark country rates. …

Green ($$$) Mountain State for drug marketing

The Mental Gymnastics blog last week posted a piece on drug company payments to Vermont doctors. vermontmap.jpg Excerpts:

“Vermont Attorney General William Sorrell released a report on pharmaceutical marketing efforts in Vermont on July 8, 2008. See the report here. Media has been reporting the aggregate amounts that psychiatrists earned the most money from these payments. Eleven psychiatrists received roughly 20 % of these funds. However, the second largest aggregate amount went to cardiologists. Two cardiologists shared payouts of $312,898, or an average of $156,440 each, no small potatoes.

An interesting finding is the medications that were promoted. The top ten medications promoted were the following:

1. Strattera (ADHD)
2. Metadate CD (ADHD)
3. Januvia (Type 2 Diabetes)
4. Lexapro (Depression)
5. Cymbalta (Depression)
6. Lantus (Diabetes)
7. Seroquel (Bi-Polar Disorder and Schizophrenia)
8. Namenda (Alzheimer’s)
9. Vytorin/Zetia (Cholesterol)
10. Benicar (Hypertension)”

Olympians pushing Botox - an "outrageous caper"

Dr. Sidney Wolfe, director of the Health Research Group at Public Citizen, released this statement yesterday:

“It is a sad day when two superb Olympic athletes - whose performances earned a total of 14 gold medals combined - prostitute themselves for undisclosed amounts of money to help Allergan sell Botox. Instead of tens of millions of people watching the athletes’ performances in the past as they strived for their personal best, people will now be able to watch videos of doctors’ performances as they inject former swimmer Mark Spitz and former gymnast Nadia Comaneci with Botox.

This sends a terrible message to athletes, young or old, and to others that they should not accept the way they look as they age but, rather, should try to look their “personal best” by the Botox-enhanced pretense that they are younger than they really are.

Local reax to USNWR hospital rankings

The annual “best hospitals” edition of US News & World Report always gets people talking.

This year’s edition certainly riled fellow UMN blogger Bill Gleason, AKA Mr. Bonzo, AKA The Whining Dinosaur, who blogs about his concerns.

How a headline can ruin a health/science story

Recently a physician friend brought the following to my attention. The same story, written by the same person, but appearing under two very different headlines.

Here’s the original New York Times headline:

NYT.png

The story stated at one point: “No one knows whether vaccinations had anything to do with the girls’ health problems, and the scientific significance of individual cases is always difficult to assess.”

But the Seattle Times picked up the NYT story and used this headline:

Seattle times.png

The Seattle headline gives the misleading impression that there’s a causal link between autism and vaccines. This is the kind of thing that gives headline writers a bad rep.

Drug industry move that doesn’t go far enough

This just in on a move that, on the surface, doesn’t go nearly far enough.

Bloomberg reports:

The U.S. pharmaceutical industry revised its code of conduct, banning gifts to doctors such as pens, mugs and restaurant meals. The drugmakers may still provide food to physicians in their offices, and pay them speaking and consulting fees.

Drugmakers’ salespeople may provide “occasional meals” in offices of health-care professionals “in conjunction with informational presentations,” the Pharmaceutical Research and Manufacturers of America said today in a statement on PR Newswire. The Washington-based lobbyist group also issued more detailed standards on continuing education and disclosure of speaking or consulting fees.

Relations between drug companies and doctors, including medical researchers, have come under scrutiny in Congress. Senator Charles Grassley, Republican of Iowa, criticized payments from Johnson & Johnson and Eli Lilly & Co. to Harvard Medical School doctors who helped pioneer the use of psychiatric drugs in children.

Reax to PHRMA’s toothless code of ethics

AP reports:

Dr. Brian Hurley, president of the American Medical Student Association, said the new rules are an improvement but they don’t go far enough. He said gifts given to doctors as educational materials or occasional meals are still gifts. “Aggressive” marketing practices have made drug companies a lot of money, he said, and they have little incentive to stop those tactics.

“Educational gifts or educational programming that pharma’s member companies put together are marketing in disguise,” he said.

The Boston Globe reports:

The Prescription Project, a Boston-based national coalition of groups that monitors pharmaceutical marketing, released a statement noting that promotional spending by the pharmaceutical industry has increased since PhRMA adopted its first guidelines on gifts in 2002. It also said that a report released this week in Vermont, one of the few states that requires disclosure of marketing payments to doctors, showed an overall 33 percent increase in pharmaceutical payments in the last year.

List of drugs doctors wouldn’t take

MSNBC.com recently posted an article from Men’s Health about the “8 Drugs Doctors Wouldn’t Take.”

The article states:

“…plenty of M.D.’s do know which prescription and over-the-counter drugs are duds, dangers, or both. So we asked them, “Which medications would you skip?”

It looks like they only asked five doctors - but here’s what they came up with:

• Advair for asthma

• Avandia for diabetes

• Celebrex for pain relief

• Ketek, antibiotic

• Prilosec & Nexium for heartburn

• Visine Original eyedrops, “to get the red out”

• Pseudoephedrine, decongestant

If they had talked with more doctors, that list could have been a lot longer than 8 drugs.

Aussies fine Lilly for Cialis promotion

The newspaper, The Australian, reports:

“THE makers of an anti-impotence treatment have been fined $60,000 for a publicity initiative that the industry’s self-regulating complaints body found breached the ban on promoting drugs direct to the public.

Eli Lilly, the maker of the erectile dysfunction drug Cialis, was also found by Medicines Australia’s Code of Conduct Committee to have issued a product-specific media statement in April this year.

The complaint was lodged over a press release issued by Eli Lilly in April, which was timed to coincide with the release of a new version of the drug called Cialis Once-a-Day.

The press release, headlined “New research reveals scheduled sex a turn-off”, reported the results of a national Galaxy poll — commissioned by Eli Lilly — which purported to show that 74 per cent of Australian men said “spontaneity … is an important part of sex”. The poll also claimed that more than half of men aged 45 to 54 “admit … that their ability to have sex on impulse has declined drastically or noticeably” since they turned 30.